Pacific Biosciences of California, Inc.
PACB News Today: Stay Updated with the Latest Pacific Biosciences of California, Inc. News in Real Time
Find PACB news now at Meyka AI. Stay informed with the latest Pacific Biosciences of California, Inc. stocks updates, including price news, market analysis, and expert insights.
TLFX Telefix (PNK) $0.0003 16 Mar 2026: Volume spike hints at liquidity shift
TLFX stock jumps to $0.0003 on 16 Mar 2026 with a volume spike, raising liquidity and trading risk questions
C$0.88 AIDX.TO Healwell AI Inc. (TSX) pre-market 16 Mar 2026: model -18% outlook
AIDX.TO stock at C$0.88 pre-market on 16 Mar 2026; Meyka model projects C$0.72 (‑18%) near-term
UBS Maintains Neutral on KinderCare Learning Companies (KLC) March 2026, PT Cut to $3
UBS keeps a Neutral view on KLC; price target cut to $3. KLC analyst rating implications for investors
Micron (MU) Expands Taiwan Footprint With New Facility Plan
Micron Technology is making waves again in the global chip industry. On March 15–16, 2026, the U.S. memory giant completed its purchase of Powerchip’s Tongluo P5 site in Taiwan and revealed plans for a second, large new manufacturing facility at that very location. This move isn’t just about more space. It’s a clear bet on…
332,900 spike on 4745.T Tokyo Indiv. (JPX) after hours Mar 2026: watch RSI
After-hours volume spike on 4745.T stock to 332,900; we analyse momentum, fundamentals and Meyka AI forecasts for JPY 446.00
CCEL (Cryo-Cell) NASDAQ pre-market -100.00% 16 Mar 2026: check listing risk
Pre-market CCEL stock drops -100% on 16 Mar 2026 after NYSE notice. Meyka AI outlook, technicals, and forecast
RBC Capital Maintains Outperform for Venture Global, Inc. (VG) March 2026
RBC keeps Outperform and raises PT to $14; VG analyst rating update and investor implications
TMD.TO Titan Medical (TSX) at C$1.13 pre-market on 117,220 vol: check catalysts 16 Mar 2026
Pre-market high-volume mover: TMD.TO stock at C$1.13 on 117,220 shares with Meyka AI analysis and forecast
EVCM EverCommerce Inc. Mar 2026 RBC Capital Maintains Sector Perform
RBC Capital maintained Sector Perform on EVCM. Read our EVCM analyst rating take and Meyka grade B+